Track G

Patentable Subject Matter for Life Sciences Inventions

Track: IP Trends and Successful Practices

Target Audience: All Audiences

Dan Polonenko

Micheline Gravelle, BsC, Msc, Bereskin & ParrLLP
Sally Sullivan, Lathrop & Gage LLP

Recent court decisions in the United States and Canada have impacted the scope of allowable claims for life science technologies such as diagnostic assays, therapeutic molecules, and sequences (nucleotide, amino acid, peptide). The panel will present and discuss current claiming strategies for these technologies for prosecution in Canada and the United States in reference to commercial value from an industry perspective.  A case study will be presented to illustrate the differences and similarities in the claiming strategies

Return to Schedule

AUTM 2016 Annual Meeting Sponsors